Search Results

Aminoglycoside use monitored by clinical pharmaceutical services.

• Authors : Barriere SL; Conte JE Jr

Subjects: Amikacin* ; Anti-Bacterial Agents* ; Drug Utilization*

• Source: American journal of hospital pharmacy [Am J Hosp Pharm] 1979 Sep; Vol. 36 (9), pp. 1209-11.Publisher: American Society Of Hospital Pharmacists Country of Publication: United States NLM ID: 0370474 Publication Model: Print Cited Medium: Print

Record details

Findings on Engineering Discussed by Investigators at Novartis (Physical Characterization of Tobramycin Inhalation Powder: I. Rational Design of a Stable Engineered-Particle Formulation for Delivery to the Lungs).

• Source: Biotech Week. 2015, pages. 480

Record details

PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF

• Source: PR Newswire Europe, November 10, 2008, 4pp

Record details

PARI Pharma Completes Successful Clinical Trials for Tobramycin 100 & Investigational eFlow for CF

• Source: PR Newswire (USA), November 10, 2008, 4pp

Record details

PARI Pharma Receives 2nd ODD From EMEA; Moves Inhaled Tobramycin - eFlow Technology Program Forward

• Source: PR Newswire (USA), May 7, 2009, 3pp

Record details

ISTA Pharmaceuticals Announces Positive Phase III Results for Tobramycin and Prednisolone Acetate Combination Product; ISTA Plans to Submit NDA for Drug Candidate in First Half of 2006; Conference Call to be Held Today at 1:30 p.m. Eastern Time

• Source: PR Newswire (USA), February 2, 2006, 3pp

Record details

Nektar Receives Patent Covering Pulmonary Targeted Antibiotics; U.S. Patent Encompassing Tobramycin Inhalation Powder and Other Aminoglycoside Antibiotics Issued to Nektar

• Source: PR Newswire (USA), May 7, 2008, 2pp

Record details

ISTA Pharmaceuticals Files New Drug Application with U.S. Food and Drug Administration for T-Pred(TM), a Tobramycin and Prednisolone Acetate Combination Product

• Source: PR Newswire (USA), July 6, 2006, 3pp

Record details

PARI Pharma's Altera Delivers Gilead's Cayston in Head-to-Head Study With Tobramycin Inhalation Solution; Cayston Achieves Co-Primary Endpoint of Non-Inferiority; Data Meet Statistical Definition of Superiority

• Source: PR Newswire (USA), June 21, 2010, 3pp

Record details

Court Rules in Favor of Alabama-Based CF Company, SourceCF, in Suit Brought by Chiron Corporation

• Source: PR Newswire (USA), May 18, 2006, 2pp

Record details